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Abstract
During an 8-month period, 24 Corynebacterium striatum isolates recovered from lower respiratory tract specimens of 10 hospitalized
patients were characterized. The organisms were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS) and by 16S rRNA gene sequencing. The cluster of C. striatum exclusively affected patients who had been admitted to an
intensive care unit and/or subsequently transferred to one medium-size respiratory care unit. Prolonged duration of hospitalization,
advanced stage of chronic obstructive pulmonary disease, recent administration of antibiotics and exposure to an invasive diagnostic
procedure were the most commonly found risk factors in these patients. Seven patients were colonized and three infected. All strains
displayed a similar broad spectrum resistance to antimicrobial agents, remaining susceptible to vancomycin only. Typing analysis by
MALDI-TOF MS and by semi-automated repetitive sequence-based PCR (DiversiLab typing) showed that all outbreak-associated C. striatum
isolates clustered together in one single type while they differed markedly from epidemiologically unrelated C. striatum isolates. Pulsed-field
gel electrophoresis (PFGE) profiles revealed three distinct PFGE types among the C. striatum isolates associated with the outbreak while all
external strains except one belonged to a distinct type. We conclude that C. striatum is an opportunistic nosocomial pathogen in long-term
hospitalized patients and can be at the origin of major outbreaks. The routine use of MALDI-TOF MS greatly facilitated the recognition/
identification of this organism in clinical samples and this technique could also offer the potential to be used as an easy and rapid
epidemiological typing tool for outbreak investigation.
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Introduction
The genus Corynebacterium refers to gram-positive bacteria
that form part of the normal microbiota of human skin and
mucous membranes and that are also widely distributed in the
environment [1,2]. The significance and prevalence of coryn-
eform bacteria are not always well established.
Corynebacterium striatum has been isolated as part of the
normal human nasopharyngeal flora and from the skin.
However, this organism has also been shown to be potentially
pathogenic in patients with chronic diseases and in specific
circumstances (e.g. following repeated exposure to
broad-spectrum antibiotics, after the use of invasive medical
procedures and in the presence of organic obstructive
pathologies) [3–5]. Most reported C. striatum infections
involved the respiratory tract and several outbreaks of
nosocomial infections have been described [6–9].
At the Mont-Godinne University Hospital (Yvoir, Belgium)
we recovered 24 C. striatum strains from respiratory samples
of 10 patients hospitalized in the intensive care unit (ICU) and
at one medical respiratory unit over an 8-month period.
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To understand the possible outbreak sources and trans-
mission routes we reviewed the medical records of all patients
from whom C. striatum was isolated over the study period.
Matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS) was used for strain identifi-
cation and was challenged as an epidemiological typing tool
through the interpretative reading of the strain spectra in the
form of a generated dendrogram. Results were compared with
semi-automated repetitive-sequence-based PCR (rep-PCR)
(DiversiLab, bioMerieux, Marcy-l’Etoile, France) and PFGE
(pulsed-field gel electrophoresis).
Material and Methods
Patients
We reviewed the medical records of all patients from whom
C. striatum isolates had been recovered from clinical specimens
for the presence of putative risk factors for nosocomial
acquisition. The study took place at UCL Mont-Godinne
University Hospital (Yvoir, Belgium), a 430-bed teaching
hospital with a laboratory mostly receiving samples from the
hospital. The status of colonization or infection was assessed
according to the CDC criteria for definition of infection [10].
Bacterial isolates
From January 2011 to August 2011, all routine specimens
yielding the isolation of C. striatum at culture and considered to
be of potential clinical significance (i.e. isolation from biolog-
ically sterile fluids or as a pure or predominant culture growth
from non-sterile clinical specimens) were collected but only
the first strain for each patient was selected for the different
analyses.
In parallel, five epidemiologically unrelated C. striatum
clinical isolates, recovered from respiratory samples, collected
from other Belgian hospitals between 2000 and 2010 and sent
for confirmation of identification to a reference laboratory
(Professor G. Wauters, Microbiology Unit, Faculty of Mede-
cine, Catholic University of Louvain, Brussels, Belgium) were
also included in the analysis for the purpose of comparison.
All C. striatum isolates were initially identified through the
clinical laboratory routine workflow by MALDI-TOF MS and
their identification was further confirmed by sequencing of the
entire 16S rRNA gene according to a previously published
method [11].
In vitro susceptibility to ten antimicrobial agents (penicillin,
ampicillin, erythromycin, clindamycin, gentamicin, tetracycline,
ciprofloxacin, co-trimoxazole, rifampicin and vancomycin) was
assessed by broth microdilution according to Clinical and
Laboratory Standards Institute guidelines [12].
MALDI-TOF MS
MALDI-TOF MS measurements were realized on a microflex
LT (Bruker Daltonik, Bremen, Germany). Spectra were
recorded by the positive linear method in a mass range from
2000 to 20000 Da.
Strain identification. Single colonies were spotted on a steel
target overlaid with 1 ll matrix solution dissolved in a basic
organic solvent composed of 50% acetonitrile and 2.5%
tri-fluor-acetic-acid. The acquired bacterial spectra with
MALDI-TOF MS were analysed in the MALDI Biotyper 2.0
software database, leading to scored identification results.
According to the specifications of the manufacturer, a high log
score  2 was required for identification to species level.
Dendrogram creation. Approximately 10 colonies of each
C. striatum isolate were scraped from a 24-h culture on
trypticase soy blood agar and added to 500 lL distilled water
followed by an ethanol-formic acid extraction procedure. One
ll of the final extraction product was spotted eight times onto
a steel target and was overlaid with 1 ll of matrix solution.
Each spot was measured three times with the MBT_FC.par
flexControl method and the MBT-autoX.axe autoExecute
method. The resulting 24 spectra were downloaded into the
MALDI BioTyper software and assembled in order to generate
a single mean spectrum accounting for the extracted strain. In
order to appreciate the correlation between the organisms
and visualize the clustering, a dendrogram was calculated.
DiversiLab typing
DNA extraction for all C. striatum strains was achieved with
the UltraClean microbial DNA isolation kit (MoBio, Carlsbad,
CA, USA) followed by DNA quantification with a NanoDrop
2000/2000C spectrophotometer (Thermofisher, Friendship,
ME, USA). The DiversiLab Bacterial fingerprint kit (Ref#
270633) was used according to the manufacturer’s instructions
to perform the rep-PCR amplification. PCR products were
detected and sized on an Agilent 2100 bioanalyser (Agilent
Technologies, Diegem, Belgium). Sample clustering was studied
by comparing the strain patterns looking for band differences
and the percentage similarity analysed. Isolates with identical
strain patterns were considered indistinguishable if the simi-
larity percentage was  97% [13].
PFGE
For PFGE analysis, C. striatum DNA was extracted using
lysozyme (20 mg/mL) and achromopeptidase (500 Units/mL).
Macrorestriction (XbaI) patterns were analysed using Dice
coefficient with Bionumerics software (Applied Maths, Kor-
trijk, Belgium). The classification criteria for PFGE analysis
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included type, designated by a capital letter and patterns
showing 0-3 DNA fragment difference corresponding to a
similarity cut-off of  80% [14].
Results
Bacterial isolates and medical records
From January 2011 to August 2011, we recovered among all
routine culture microbiological samples a total of 24 clinical
isolates of C. striatum. All strains originated from lower
respiratory tract specimens of 10 distinct hospitalized patients.
The 24 strains were correctly identified to the species [log
(score)  2] with MALDI-TOF MS. 16S rRNA gene sequences
of the 10 analysed strains (one strain/patient) showed  99.6%
similarity with the sequence from C. striatum type strain
NCTC 764T. All C. striatum clinical isolates displayed an
identical multidrug resistance pattern with susceptibility to
vancomycin only. The five epidemiologically unrelated C. stri-
atum strains showed a less resistant profile as all isolates were
susceptible to penicillin, ampicillin, erythromycin, clindamycin
and vancomycin while showing heterogenous profiles to the
other antibiotics (data not shown).
The clinical characteristics of the patients are presented in
Table 1. According to CDC criteria, seven patients were
considered to be colonized and three infected. All affected
patients had been hospitalized for prolonged periods before the
first isolation of C. striatum (mean, 33 days; range, 5–90 days).
During the outbreak, at least one colonized or infected
patient was hospitalized in the ICU or in the medical respiratory
unit at the time by which a new carrier of C. striatum was
detected (Fig. 1). Eight of the 10 patients had major co-mor-
bidities and had been exposed to multiple previous courses of
antibiotic treatment. Eight patients did undergo a bronchial
fibroscopy and five patients were intubated. Themedical care of
eight patients required the use of invasive medical devices.
Finally, nine patients were discharged from the hospital while
one colonized patient died during his stay.
Epidemiological analysis
Dendrogram with MALDI-TOF MS. The dendrogram (Fig. 2)
generated from the 15 registered C. striatum spectra pointed
out a distinctive cluster assembling the 10 outbreak-related
C. striatum strains and the external strains 4 and 5 with a
maximum distance level of 100. The acquired spectra of three
out of the five unrelated tested C. striatum external strains
showed a distinct spectrum pattern.
DiversiLab typing. All 10 outbreak-related C. striatum isolates
had the same repPCR patterns and had  97.7% similarity TA
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level between each other while the five epidemiologically
non-related strains displayed different strain patterns, with
similarity levels <97% between each other (Fig. 3).
PFGE. PFGE delineated the 10 C. striatum patient strains into
three distinct PFGE types (Fig. 3). Type A comprised the
outbreak-related C. striatum isolates from patients 1 to 7 and
C. striatum external isolate 5. Type F comprised the C. striatum
isolates from patients 8 and 9. Finally Type H was a singleton
only including the C. striatum patient 10 strain.
The analysis of the four leftover C. striatum epidemiologi-
cally non related strains led to four singleton PFGE types (B, C,
D and G).
Discussion
Over recent years Corynebacteria have been recognized as
opportunistic pathogens able to cause various types of
healthcare-associated infections in immunocompromised hosts
[2]. It is therefore essential for each clinical microbiology
laboratory to use techniques that identify correctly and rapidly
these bacteria. Identification of Corynebacteria by conventional
methods is suboptimal and it is likely that their true prevalence
in clinical specimens either as colonizers or as pathogens is
largely underestimated. MALDI-TOF MS has proven accuracy
for rapid identification of toxigenic Corynebacterium
Patient 10
Patient 9
Patient 8
Patient 7
Patient 6
Patient 5
Patient 4
Patient 3
Patient 2
Patient 1
Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11
FIG. 1. Hospital route of the 10 C. striatum colonized/infected patients between January and August 2011 □, presence in intensive care unit; ○,
presence in medical respiratory unit; grey symbols, respiratory samples that were culture-negative for C. striatum; black symbols, respiratory samples
that were culture-positive for C. striatum.
Cs patient 2
01002003004005006007008009001000
Distance Level
Cs patient 8
Cs patient 1
Cs patient 5
Cs patient 4
Cs patient 7
Cs patient 6
Cs patient 3
Cs patient 10
Cs patient 9
External Cs 5
External Cs 4
External Cs 1
External Cs 2
External Cs 3
FIG. 2. Dendrogram of the C. striatum strains of the 10 colonized/infected hospital patients and of five external C. striatum strains. Cs,
Corynebacterium striatum.
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species and non-diphtheria Corynebacterium, including C. stri-
atum [15–17].
In our setting, the repeated identification of C. striatum in
clinical respiratory samples of several hospitalized patients
over a limited period of time raised the suspicion of an ongoing
outbreak. While only one C. striatum isolate had been recov-
ered from a hospitalized patient in the preceding 8-month
baseline period, we identified 24 clinical C. striatum isolates in
10 distinct hospitalized patients over the 8 following months,
corresponding to an attack rate of 10 to 1. Following this
observation, we established the ‘outbreak case definition’ as
each hospitalized patient with a clinical sample growing mainly
or exclusively C. striatum colonies. A retrospective investiga-
tion of the patients’ medical records was carried out to
describe the outbreak population. Several risk factors were
identified in our patients. The most frequently found under-
lying co-morbidity in our series was chronic obstructive
pulmonary disease for eight of the ten patients. It is very likely
that such long-lasting chronic disease along with the frequent
use of respiratory equipment did contribute to the respiratory
tract colonization and the infectious potential of this organism
in immunocompromised patients. Previous exposure to anti-
biotic treatment observed in eight patients also most likely
contributed to the overgrowth of this multidrug-resistant
organism through selective pressure.
Upon the case definition and the subsequent analysis of risk
factors, an epidemic curve (date not shown) and a spatial/
temporal distribution (Fig. 1) were drawn, aiming to under-
stand the routes of transmission and sources of the C. striatum
outbreak. Figure 1 highlights the particularity of this outbreak,
which was ongoing simultaneously in two units despite the fact
that the medical and ICU wards were geographically separated
and that each unit was staffed with distinct medical and
nursing teams. The colonized/infected patients probably
constituted the reservoirs of transmission because all had a
very long hospital stay and at least one colonized patient was
always present in one of the two affected units during the
outbreak period at the time by which a new case of C. striatum
was recognized. We considered as the most probable
scenario that patient #2 who had been nursed in contact
with the index case (patient #1) in the ICU in January 2011
and who was subsequently transferred to the respiratory
medical unit, was at the origin of the dissemination of this
strain between the two units. The healthcare staff in both
units are strongly suspected to be the vector of cross-trans-
mission of the C. striatum strain between patients. In a
previous report, Brandenburg et al. reported the 12-month
persistence of a single C. striatum epidemic strain in patients in
a surgical ICU, suggesting that asymptomatically colonized
patients may constitute the main reservoir of C. striatum and
that patient-to-patient transmission probably occurs via the
hands of the personnel [7]. Our study hereby highlights the
protracted and silencious pattern of a C. striatum outbreak.
Based on all these elements, an alert was issued by the
infection control team to reinforce hand hygiene practice and
barrier precautions.
In parallel, a laboratory investigation of the out-
break-related C. striatum strains was performed. Several
molecular typing methods (DNA fingerprinting and genotyp-
ing) have been used to demonstrate an epidemiological link
between the isolates in previously described C. striatum
outbreaks [6–8]. These methods nevertheless require highly
FIG. 3. DiversiLab typing and PFGE clone types of the C. striatum strains of the 10 colonized/infected hospitalized patients and five epidemiologically
unrelated strains (‘external’ C. striatum strains). Cs, Corynebacterium striatum; DL, DiversiLab; PFGE, pulsed-field gel electrophoresis.
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qualified staff and expensive dedicated material and they
usually require several days or weeks before results are
obtained and a feedback is given to the units. MALDI-TOF MS
has proven to be reliable for identification of bacteria but as
yet there have been only few studies that have assessed the
value of this technique as an epidemiological typing tool in the
setting of a noscomial outbreak [18]. In our study we aimed to
set up an easy and fast subtyping technique accessible to any
MALDI-TOF MS user. The technique was based on an
ethanol-formic acid strain extraction method (routine test
for difficult strains) and a dendrogram cluster analysis only
requiring the Maldi BioTyper Software without any additional
statistical tool. We determined the diversity of the C. striatum
isolates collected in the setting of our local outbreak and
compared these strains with epidemiologically unrelated
isolates collected from specimens in several hospitals. All
outbreak-related strains clustered in a single clone both by
MALDI-TOF MS dendrogram and with the DiversiLab typing
method. Yet, two epidemiologically unrelated isolates (exter-
nal C. striatum strains #4 and #5 also) clustered within the
outbreak cluster in the dendrogram while they corresponded
to a different clone type with DiversiLab. PFGE analysis
subdivided the ten outbreak-associated C. striatum strains into
three clusters (A, F and H). Cluster A included the first seven
patient strains and C. striatum external strain #5, an observa-
tion also made with the MALDI-TOF MS dendrogram.
Interestingly, by PFGE the strains were found to be grouped
into three different types according to chronological sequence
(time) of isolation (i.e. cluster A included patient strains #1 to
#7, cluster F strains #8 and #9, and finally cluster H strain
#10). As the duration of this outbreak had spanned over an
8-month period, it may well be possible that the C. striatum
outbreak strain had undergone some chromosomal changes
that might have been detected by PFGE analysis, considered as
a highly sensitive molecular epidemiological tool. In conclu-
sion, typing results by MALDI TOF MS were subsequently
confirmed by intergenic rep PCR typing analysis but both
methods appeared slightly less discriminant than PFGE for
recognition and differentiation of certain clonal lineages. Based
on a diversity analysis of C. striatum strains by MALDI-TOF MS
and by a multigenic sequencing approach, Gomila et al.
similarly suggested that MALDI-TOF MS could be an efficient
tool for discrimination of bacterial strains below the species
level though not as discriminatory as the other molecular
typing techniques [17].
A hospital outbreak is never a coincidence but a reflection
of a failure in the infection control measures. In line with
several previous reports, our study once more highlights the
role of C. striatum in nosocomial outbreaks mostly affecting
immunocompromised patients [4–9].
Based on our experience, we believe that rapid confirmation
of the spread of a single clone/type of a nosocomial pathogen
within or across several hospital units by a locally available typing
method such as MALDI-TOF MS may contribute to improving
the management of an outbreak. This study is one of the first to
document the potential usefulness of MALDI TOF MS as a
subtyping tool for investigating nosocomial outbreaks. Further
studies are, however, needed to confirm our observations.
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